Profili legali della sperimentazione clinica
DOI: https://doi.org/10.7175/pmeal.v3i4.377
Abstract
The iter of a clinical trial includes some steps: except for the earliest one, the preclinical phase, each step involves human beings that could be exposed to adverse events or unknown reactions caused by the new treatment. Starting from Nuremberg Code in 1949, an in-depth legislation has been developed to define the relationship between the two protagonists of the clinical trial: the experimenter and the volunteer or patient who takes the new drug. Responsibilities and possible faults are established, taking into account patient’s rights to be preserved and informed of the risks and experimenter’s responsibility in case of not-predictable side effects.
Parole chiave
Trial; Nuremberg Code; Informed consent; Risks of experimentation
Testo completo
Statistiche
Abstract: 350 visualizzazioniPDF: 562 visualizzazioni
Refback
- Non ci sono refbacks, per ora.
Copyright (c) 2012